Author details

Full Name

Joe W Gray

Affiliation

Oregon Health and Science University

ORCID

Career Start Year

1974

Papers

484

H Index

115

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37439796	Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.	Clin Cancer Res	2023
37928169	3D multiplexed tissue imaging reconstruction and optimized region of interest (ROI) selection through deep learning model of channels embedding.	Front Bioinform	2023
37745323	Digitize your Biology! Modeling multicellular systems through interpretable cell behavior.	bioRxiv	2023
38076794	Towards Generalizability and Robustness in Biological Object Detection in Electron Microscopy Images.	bioRxiv	2023
37704631	MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer.	Nat Commun	2023
37961180	Efficient semi-supervised semantic segmentation of electron microscopy cancer images with sparse annotations.	bioRxiv	2023
37613256	Large-Scale Electron Microscopy to Find Nanoscale Detail in Cancer.	Microsc Microanal	2023
37439796	Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.	Clin Cancer Res	2023
38076794	Towards Generalizability and Robustness in Biological Object Detection in Electron Microscopy Images.	bioRxiv	2023
37961180	Efficient semi-supervised semantic segmentation of electron microscopy cancer images with sparse annotations.	bioRxiv	2023
37704631	MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer.	Nat Commun	2023
37745323	Digitize your Biology! Modeling multicellular systems through interpretable cell behavior.	bioRxiv	2023
37613256	Large-Scale Electron Microscopy to Find Nanoscale Detail in Cancer.	Microsc Microanal	2023
37928169	3D multiplexed tissue imaging reconstruction and optimized region of interest (ROI) selection through deep learning model of channels embedding.	Front Bioinform	2023
35322205	A multi-encoder variational autoencoder controls multiple transformational features in single-cell image analysis.	Commun Biol	2022
36233691	Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention.	J Clin Med	2022
36207580	A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.	Commun Biol	2022
35871223	Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.	Nat Commun	2022
35545666	A framework for multiplex imaging optimization and reproducible analysis.	Commun Biol	2022
35788566	A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.	Nat Biotechnol	2022
35322205	A multi-encoder variational autoencoder controls multiple transformational features in single-cell image analysis.	Commun Biol	2022
35243422	An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.	Cell Rep Med	2022
35083840	Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis.	Small	2022
35545666	A framework for multiplex imaging optimization and reproducible analysis.	Commun Biol	2022
35788566	A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.	Nat Biotechnol	2022
35871223	Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.	Nat Commun	2022
36207580	A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.	Commun Biol	2022
36233691	Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention.	J Clin Med	2022
35243422	An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.	Cell Rep Med	2022
35083840	Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis.	Small	2022
33443130	Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.	Mol Cancer Res	2021
34118167	In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response.	Adv Mater	2021
34222745	<i>Ex Vivo</i> Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.	Annu Rev Cancer Biol	2021
33886505	The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.	JCI Insight	2021
33772089	Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.	NPJ Precis Oncol	2021
33443130	Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.	Mol Cancer Res	2021
34250408	Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer.	JCO Precis Oncol	2021
34086259	Chemokine signaling in cancer-stroma communications.	J Cell Commun Signal	2021
34344439	Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.	Breast Cancer Res	2021
34667258	Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.	NPJ Precis Oncol	2021
34903759	Oligonucleotide conjugated antibody strategies for cyclic immunostaining.	Sci Rep	2021
34485971	Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms.	Cell Rep Methods	2021
33886505	The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.	JCI Insight	2021
33772089	Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.	NPJ Precis Oncol	2021
34903759	Oligonucleotide conjugated antibody strategies for cyclic immunostaining.	Sci Rep	2021
34667258	Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.	NPJ Precis Oncol	2021
34485971	Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms.	Cell Rep Methods	2021
34222745	<i>Ex Vivo</i> Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.	Annu Rev Cancer Biol	2021
34250408	Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer.	JCO Precis Oncol	2021
34344439	Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.	Breast Cancer Res	2021

1 - 50 of 968

Darawalee Wangsa

Center for Cancer Research, National Cancer Institute

Career Start Year 2005

Number of shared co-authors 3

James Hicks

Michelson Center for Convergent Bioscience, University of Southern California

Career Start Year 2004

Number of shared co-authors 14

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Sven Bilke

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2001

Number of shared co-authors 9

Sandra Burkett

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 4

Danny Wangsa

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 5

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 16

Qing-Rong Chen

Center for Biomedical Informatics and Information Technology

Career Start Year 1996

Number of shared co-authors 4

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 24

Alexei Protopopov

The University of MD Anderson Cancer Center

Career Start Year 1995

Number of shared co-authors 37

Jane Bayani

Ontario Institute for Cancer Research

Career Start Year 1995

Number of shared co-authors 5

Michael R Emmert-Buck

The Francis Crick Institute

Career Start Year 1994

Number of shared co-authors 11

Susan J Done

University Health Network

Career Start Year 1994

Number of shared co-authors 1

Sarah L Anzick

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1993

Number of shared co-authors 4

Abdel G Elkahloun

National Human Genome Research Institute

Career Start Year 1990

Number of shared co-authors 8

Suzanne Kamel-Reid

Toronto General Hospital, University Health Network, University of Toronto

Career Start Year 1988

Number of shared co-authors 7

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 45

Jonathan R Pollack

Stanford University School of Medicine

Career Start Year 1987

Number of shared co-authors 16

Mark A Watson

Washington University School of Medicine

Career Start Year 1987

Number of shared co-authors 28

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 11

Peter Lichter

German Cancer Research Center (DKFZ)

Career Start Year 1986

Number of shared co-authors 26

Ann M Killary

The University of Texas M. D. Anderson Cancer Center

Career Start Year 1984

Number of shared co-authors 7

Ching C Lau

Baylor College of Medicine

Career Start Year 1982

Number of shared co-authors 23

Ashok R Venkitaraman

University of Cambridge, Hutchison Research Centre

Career Start Year 1982

Number of shared co-authors 7

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 16

Jeremy A Squire

University of Sao Paulo

Career Start Year 1982

Number of shared co-authors 6

David J Adams

Wellcome Sanger Institute

Career Start Year 1980

Number of shared co-authors 24

Colin S Cooper

Norwich Medical School, University of East Anglia

Career Start Year 1978

Number of shared co-authors 13

David W Hedley

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1975

Number of shared co-authors 3

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 34

row(s) 1 - 30 of 30